‘Moderate-risk’ ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation

P. J. HOSKINS; K. D. SWENERTON; M. MANJI; F. WONG; S. E. O'REILLY; E. J. McMURTRIE; N. LE; B. ACKER; J. LE RICHER

doi:10.1046/j.1525-1438.1994.04040272.x

Article info

Original Articles

‘Moderate-risk’ ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation

Authors

P. J. HOSKINS Division of Medical OncologyDivision of Radiation Oncology PubMed articles Google scholar articles
K. D. SWENERTON Division of Medical OncologyDivision of Gynecologic Oncology PubMed articles Google scholar articles
M. MANJI Division of Radiation OncologyDivision of Gynecologic Oncology PubMed articles Google scholar articles
F. WONG Division of Radiation OncologyDivision of Gynecologic Oncology PubMed articles Google scholar articles
S. E. O'REILLY Division of Medical OncologyDivision of Gynecologic Oncology PubMed articles Google scholar articles
E. J. McMURTRIE Division of Gynecologic Oncology PubMed articles Google scholar articles
N. LE Division of Epidemiology PubMed articles Google scholar articles
B. ACKER Division of Radiation OncologyDivision of Gynecologic Oncology PubMed articles Google scholar articles
J. LE RICHER Department of Pathology, Vancouver Clinic, British Columbia Cancer Agency, Vancouver, Canada PubMed articles Google scholar articles

Address for correspondence: Dr P. J. Hoskins, B.C. Cancer Agency, 600 West Tenth Avenue, Vancouver, B.C. Canada V5Z 4E6.

Citation

HOSKINS PJ, SWENERTON KD, MANJI M, et al

‘Moderate-risk’ ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation

International Journal of Gynecologic Cancer 1994;4:272-278.

Publication history

First published July 1, 1994.

Online issue publication

December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

International Gynecologic Cancer Society

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password